Hepatitis B Disease Forecast and Market Analysis to 2035 - ResearchAndMarkets.com

DUBLIN--()--The "Hepatitis B disease forecast and market analysis to 2035" report has been added to ResearchAndMarkets.com's offering.

Hepatitis B is a viral infection caused by the hepatitis B virus (HBV) that attacks the liver and can cause both acute and chronic disease. HBV is transmitted perinatally from mother to child and through contact with infected blood or other bodily fluids. Despite a safe and effective vaccine being available, HBV continues to represent a major health problem and can lead to acute liver failure, acute hepatitis, chronic hepatitis, liver cirrhosis, liver cancer, liver transplantation, and death.

Key Topics Covered:

Overview

Disease Background

Methodology

Forecast

High-Risk Group Prevalence

Appendix: Additional Sources

Bibliography

For more information about this report visit https://www.researchandmarkets.com/r/b7ccz1

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs